The agency approved the first over-the-counter continuous glucose monitor, known as Stelo, for adults with diabetes who do ...

If a patient receives a continuous glucose monitor device through their medical benefit, they may be more adherent and may ...

Their research has been published in Science Advances, titled "Coin-sized, fully integrated, and minimally invasive ...

Continuous glucose monitors are small devices that automatically track your blood sugar, aka your blood glucose level, ...

Real-world data showed reductions in healthcare resource utilization and improved glycemic control over 1 year with ...

Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of ...

Continuous glucose monitoring, compared with fingerstick tests, was feasible and accurate in an inpatient setting among patients and nurses.

After collecting FDA green lights for 90- and 180-day versions, the agency has cleared the latest generation of the Eversense ...

Senseonics, a medtech manufacturer developing long-term, implantable continuous glucose monitoring (CGM) systems, and ...

Eversense 365 is a fully-implantable CGM with a 365-day sensor, making it the first 1-year CGM option for diabetes management ...

St. Louis-based diabetes treatment startup Aegis Digital Health is nearing $1 million in its latest funding round and seeing ...